Impact of tinidazole gargle and dentong Xiaoyanling on gingival sulcus factor, dental health, and periodontal metrics in chronic periodontitis
Keywords:
speeds up symptom relief, Dentong, XiaoyanlingAbstract
The goal is to find out how intense tinidazole gargles in addition to Dentong Xiaoyanling affect patients with chronic periodontitis.
Techniques: Ninety-six (96) patients with chronic periodontitis who were admitted to Chun'an County Traditional Chinese Hospital in
Qiandaohu Town, China between January 2021 and December 2022 were split into two groups at random: the study group received
Dentong Xiaoyanling in addition to concentrated tinidazole gargle treatment, while the control group received the same treatment. The
two groups' clinical efficacy, adverse responses, oral health status, gingival sulcus factor (GSF), and periodontal markers were compared.
Results: Before treatment, there were no significant differences (p > 0.05) between the two groups' periodontal markers, GSF, or oral
health score. However, the periodontal markers, GSF, and oral health score of the two groups substantially decreased (p < 0.05) after
therapy with Dentong Xiaoyanling and/or concentrated tinidazole gargle, with the study group seeing more dramatic reductions. The
group that received treatment with a combination of Dentong Xiaoyanling and concentrated tinidazole gargle had a considerably greater
(p < 0.05) level of clinical effectiveness (91.67%) compared to the control group (75%). Additionally, there was no discernible difference
in the two groups' incidence of adverse events before and after therapy (p > 0.05).
In summary, treating chronic periodontitis with a concentrated tinidazole gargle combined with Dentong Xiaoyanling reduces gum
inflammation locally, speeds up symptom relief, and increases dental health. Further methodologies will need an expanded sample size
from a variety of clinical contexts to validate the efficacy of this technique.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.











